Rae Caroline D, Williams Stephen R
Neuroscience Research Australia, Barker St Randwick, NSW 2031, Australia; School of Medical Science, The University of New South Wales, NSW, 2052, Australia.
Division of Informatics, Imaging and Data Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Anal Biochem. 2017 Jul 15;529:127-143. doi: 10.1016/j.ab.2016.12.022. Epub 2016 Dec 26.
We review the transport, synthesis and catabolism of glutathione in the brain as well as its compartmentation and biochemistry in different brain cells. The major reactions involving glutathione are reviewed and the factors limiting its availability in brain cells are discussed. We also describe and critique current methods for measuring glutathione in the human brain using magnetic resonance spectroscopy, and review the literature on glutathione measurements in healthy brains and in neurological, psychiatric, neurodegenerative and neurodevelopmental conditions In summary: Healthy human brain glutathione concentration is ∼1-2 mM, but it varies by brain region, with evidence of gender differences and age effects; in neurological disease glutathione appears reduced in multiple sclerosis, motor neurone disease and epilepsy, while being increased in meningiomas; in psychiatric disease the picture is complex and confounded by methodological differences, regional effects, length of disease and drug-treatment. Both increases and decreases in glutathione have been reported in depression and schizophrenia. In Alzheimer's disease and mild cognitive impairment there is evidence for a decrease in glutathione compared to age-matched healthy controls. Improved methods to measure glutathione in vivo will provide better precision in glutathione determination and help resolve the complex biochemistry of this molecule in health and disease.
我们综述了谷胱甘肽在大脑中的转运、合成与分解代谢,以及其在不同脑细胞中的区室化和生物化学特性。对涉及谷胱甘肽的主要反应进行了综述,并讨论了限制其在脑细胞中可用性的因素。我们还描述和评价了目前使用磁共振波谱法测量人脑中谷胱甘肽的方法,并综述了有关健康大脑以及神经、精神、神经退行性和神经发育疾病中谷胱甘肽测量的文献。总之:健康人脑谷胱甘肽浓度约为1 - 2 mM,但因脑区而异,有性别差异和年龄效应的证据;在神经疾病中,多发性硬化症、运动神经元病和癫痫中谷胱甘肽似乎减少,而在脑膜瘤中则增加;在精神疾病中,情况复杂,受方法差异、区域效应、疾病时长和药物治疗的影响;抑郁症和精神分裂症中均有谷胱甘肽增加和减少的报道。与年龄匹配的健康对照相比,阿尔茨海默病和轻度认知障碍中有证据表明谷胱甘肽减少。改进的体内测量谷胱甘肽的方法将在谷胱甘肽测定中提供更高的精度,并有助于解析该分子在健康和疾病中的复杂生物化学特性。